Inactive Instrument

Highlights Golden Sun Capital Inc Toronto S.E.

Equities

GSTh

CA38123A1093

End-of-day quote Toronto S.E. Other stock markets
-	-

Jun. 11	Voyageur Pharmaceuticals Ltd. and Rain Cage Carbon Inc. Announce Follow Up on the First Commercial Creation of V@C60 Endohedral Fullerene	CI
May. 28	Voyageur Pharmaceuticals Ltd Secures USD 1.9 Million Sales Contract for SmoothXTM 2% Barium Contrast	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Voyageur Pharmaceuticals Ltd. and Rain Cage Carbon Inc. Announce Follow Up on the First Commercial Creation of V@C60 Endohedral Fullerene	Jun. 11	CI
Voyageur Pharmaceuticals Ltd Secures USD 1.9 Million Sales Contract for SmoothXTM 2% Barium Contrast	May. 28	CI
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended February 29, 2024	Apr. 26	CI
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2023	Mar. 26	CI
Voyageur Pharmaceuticals Ltd. Announces A Significant Advancement in Its Partnership with Rain Cage Carbon Inc	Mar. 13	CI
Voyageur Pharmaceuticals Ltd. and Applied Pharmaceutical Innovation Sign Master Services Agreement	Mar. 04	CI
Voyageur Pharmaceuticals Ltd. Announces the Formalization of A Pivotal Sales and Distribution Alliance	Dec. 14	CI
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	23-10-30	CI
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023	23-07-31	CI
Voyageur Pharmaceuticals Ltd. Announces the Release of the White Paper	23-06-12	CI
Voyageur Pharmaceuticals Ltd. Advances with Environmental Field Work At Frances Creek Project Site for Notice of Work & Quarry Permitting	23-05-31	CI
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended February 28, 2023	23-04-28	CI
Voyageur Pharmaceuticals Ltd. Completes Comparative Studies of Its SmoothX® Contrast Media Confirming Product Superiority	23-04-06	CI
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2022	23-03-30	CI
Voyageur Pharmaceuticals Ltd. Announces Canadian Launch of Smoothx Barium Contrast Media & Financing	22-12-08	CI
Voyageur Pharmaceuticals Ltd. Completes Medical Imaging CT Contrast Agent Production Testing and Begins Production Scale-Up of SmoothX	22-11-28	CI
Voyageur Pharmaceuticals Ltd. Completes Design of Carbon Neutral Pharmaceutical Facility on Alberta	22-11-01	CI
Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022	22-10-31	CI
Voyageur Pharmaceuticals’ MOU with Rain Cage Carbon to Develop Fullerene-Based Medical Contrast Agents from Carbon Capture of Hydrocarbon Exhaust Systems	22-10-26	CI
Voyageur Pharmaceuticals Ltd Signs Memorandum of Understanding with Rain Cage Carbon Inc	22-10-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Golden Sun Capital Inc Toronto S.E.

Equities

GSTh

CA38123A1093

Highlights

Filters